1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 2: Thalamic volumetry and DTI findings at study entry and after 15 months in patients with PPMS with and without thalamic T2-visible lesionsa
Variables PPMS without Lesions PPMS with Lesions P Value NTV Baseline 4.49 (0.88) 3.62 (0.74) .001 % Change −3.7 (5.5) −5.8 (6.5) .22 Thalamic MD Baseline 1.01 (0.13) 1.19 (0.19) .001 % Change +2.4 (10.8) +0.9 (9.1) .60 Thalamic FA Baseline 0.21 (0.02) 0.20 (0.02) .05 % Change −12.8 (7.1) −11.7 (7.2) .60
-
a Values are means ± SDs in parentheses. See the text for statistical analysis.